Streetbeat News

Analyst Ratings

AVDL

Needham analyst Ami Fadia reiterates a Buy rating on Avadel Pharmaceuticals (NASDAQ:AVDL) and raises the price target from $14 to $18.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:34 am

HEI

Vertical Research analyst Robert Stallard upgrades Heico (NYSE:HEI) from Hold to Buy and announces a $191 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:28 am

KVUE

RBC Capital analyst Nik Modi initiates coverage on Kenvue (NYSE:KVUE) with an Outperform rating and announces a price target of $29.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:26 am

CRM

Canaccord Genuity analyst David Hynes maintains a Buy rating on Salesforce (NYSE:CRM) and raises the price target from $215 to $230.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:18 am

DIS

Truist Securities analyst Matthew Thornton maintains a Buy rating on Walt Disney (NYSE:DIS) but lowers the price target from $121 to $105.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2023 | 10:17 am

CFLT

Needham analyst Mike Cikos initiates coverage on Confluent (NASDAQ:CFLT) with a Buy rating and announces a price target of $35.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:13 am

RMTI

HC Wainwright & Co. analyst Raghuram Selvaraju maintains a Buy rating on Rockwell Medical (NASDAQ:RMTI) and raises the price target from $7 to $9.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:11 am

CTXR

HC Wainwright & Co. analyst Vernon Bernardino reiterated a Buy rating on Citius Pharma (NASDAQ:CTXR) and maintained a $6 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:10 am

CAN

HC Wainwright & Co. analyst Kevin Dede reiterated a Buy rating on Canaan (NASDAQ:CAN) and maintained a $4 price target.

Portfolio Pulse from richadhand@benzinga.com

May 30, 2023 | 10:10 am